Anti-Diabetic Effect of a Polysaccharide Fraction From Momordica Charantia: Modulation of Notch Signaling
Abstract Given the impact of notch signaling in the modulation of metabolic diseases and normal tissue homeostasis, this study aimed to evaluate whether notch signaling has a role in anti-diabetic and islet regenerative effects of isolated polysaccharide from Memordica charantia in diabetic rats. The polysaccharide was isolated from Memordica charantia (MCP) and characterized using FTIR and LC-MS/MS. Diabetic model was established by intrapritoneal administration of STZ in male Wistar rats. The levels of Hes1, Notch 1, DLL4, Jagged1, Pdx1, CD34, CD31 and VEGF were analyzed by using immunohistochemistry and real-time PCR. Structural analyses have revealed the carbohydrate structure of fraction. Blood glucose was halted by treatment with fraction. MCP scaled up the mRNA levels of Ins1, jagged1, Pdx1 and Hes1 while scaled down the levels of Notch1, Dll4 and the ratio of Bax/Bcl2 in diabetic rats. Furthermore, the immunohistochemistry staining of hes1, cyclin d1 and VEGF proteins was increased in the pancreas of MCP-treated diabetic rats compared to the diabetic group. These findings provide insights into the anti-diabetic potential of MCP through modulation of islets regeneration and suggest that modulation of notch and angiogenesis pathways may play the pivotal role in the restoration of islets to relieve diabetes.